The Luminescent Conjugated Oligothiophene h‑FTAA Attenuates the Toxicity of Different Aβ Species

• Main Authors: Linnea Sandin (118594), Simon Sjödin (11372052), Ann-Christin Brorsson (251701), Katarina Kågedal (118606), Livia Civitelli (153987)
• Format: Other Non-Article Part of Journal/Newspaper
• Language: unknown
• Published: 2021
• Subjects: Biophysics; Biochemistry; Neuroscience; Ecology; Cancer; Inorganic Chemistry; Science Policy; Plant Biology; Biological Sciences not elsewhere classified; Chemical Sciences not elsewhere classified; luminescent conjugated oligothiophenes; cell viability assays; cause neuronal dysfunction; binding assay experiments; ftaa either interact; ftaa ); changed; thus showing h; stage amyloid fibrils; arc </ sub; aβ aggregation linked; different aβ species; different ways; different species; ftaa protects; useful tool; stronger impact; prion protein; previous study; prevailing opinion; prefibrillar β; arctic mutation; amyloid proteins; alzheimer ’; aggregation kinetics; Arctic
• Online Access: https://doi.org/10.1021/acs.biochem.1c00265.s001

The prevailing opinion is that prefibrillar β-amyloid (Aβ) species, rather than end-stage amyloid fibrils, cause neuronal dysfunction in Alzheimer’s disease, although the mechanisms behind Aβ neurotoxicity remain to be elucidated. Luminescent conjugated oligothiophenes (LCOs) exhibit spectral properties upon binding to amyloid proteins and have previously been reported to change the toxicity of Aβ 1–42 and prion protein. In a previous study, we showed that an LCO, pentamer formyl thiophene acetic acid (p-FTAA), changed the toxicity of Aβ 1–42 . Here we investigated whether an LCO, heptamer formyl thiophene acetic acid (h-FTAA), could change the toxicity of Aβ 1–42 by comparing its behavior with that of p-FTAA. Moreover, we investigated the effects on toxicity when Aβ with the Arctic mutation (Aβ Arc ) was aggregated with both LCOs. Cell viability assays on SH-SY5Y neuroblastoma cells demonstrated that h-FTAA has a stronger impact on Aβ 1–42 toxicity than does p-FTAA. Interestingly, h-FTAA, but not p-FTAA, rescued the Aβ Arc -mediated toxicity. Aggregation kinetics and binding assay experiments with Aβ 1–42 and Aβ Arc when aggregated with both LCOs showed that h-FTAA and p-FTAA either interact with different species or affect the aggregation in different ways. In conclusion, h-FTAA protects against Aβ 1–42 and Aβ Arc toxicity, thus showing h-FTAA to be a useful tool for improving our understanding of the process of Aβ aggregation linked to cytotoxicity.